{
  "hits": 306,
  "size": 50,
  "data": [
    {
      "title": "地氟烷美国首仿上市，国际化征程再进一步",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2018-03-02 00:00:00.000",
      "infoCode": "AP201803021097537138",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "51.5000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000232234.王冯"
      ],
      "indvIsNew": "001",
      "researcher": "王冯",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 657,
      "attachPages": 11,
      "encodeUrl": "5baDmlWC64CoZncqJqCjqQU15Q36lLBwaHLlf74pNjg=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000232234"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "事件点评：地氟烷FDA首仿获批，高壁垒品种竞争格局极佳有望快速放量",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2018-03-01 00:00:00.000",
      "infoCode": "AP201803011096190980",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3600000000",
      "predictLastYearPe": "53.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210529.张金洋",
        "11000249425.胡偌碧"
      ],
      "indvIsNew": "001",
      "researcher": "张金洋,胡偌碧",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 555,
      "attachPages": 7,
      "encodeUrl": "mTI1CASI1idRE3sDSR0q1UflFDJqUzHbCQWI4MKohuw=",
      "sRatingName": "推荐",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000210529",
        "11000249425"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "加速成为国内领先、国际一流的综合性药企",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2018-02-27 00:00:00.000",
      "infoCode": "AP201802270013014032",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.8000000000",
      "predictLastYearPe": "41.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "93.8000000000",
      "indvAimPriceL": "93.8000000000",
      "attachType": "0",
      "attachSize": 9444,
      "attachPages": 129,
      "encodeUrl": "7FW8rVZHtTmZPK/DNGRarYFo2usPQtKcyMXnkbxg7Iw=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "深度报告：创新药重磅频频，国际化锦上添花",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80174696",
      "orgName": "莫尼塔投资",
      "orgSName": "莫尼塔投资",
      "publishDate": "2018-01-31 00:00:00.000",
      "infoCode": "AP201801311084456987",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000250128.张静含",
        "11000240930.贾雅希"
      ],
      "indvIsNew": "001",
      "researcher": "张静含,贾雅希",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1493,
      "attachPages": 28,
      "encodeUrl": "xYNadOmnmmk2sOrzZw2KzGivx4nFTGXt6Sg8B3BYSZA=",
      "sRatingName": "",
      "sRatingCode": "",
      "market": "SHANGHAI",
      "authorID": [
        "11000250128",
        "11000240930"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药再获临床，研发梯队不断壮大",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000155",
      "orgName": "上海证券有限责任公司",
      "orgSName": "上海证券",
      "publishDate": "2018-01-18 00:00:00.000",
      "infoCode": "AP201801181079206118",
      "column": "002004006001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3500000000",
      "predictLastYearPe": "54.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000235631.杜臻雁"
      ],
      "indvIsNew": "001",
      "researcher": "杜臻雁",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 476,
      "attachPages": 4,
      "encodeUrl": "8qbM7MCLZNnHInKdZFHKjN6FurfeGNVIQsdE7dnQkXU=",
      "sRatingName": "增持",
      "sRatingCode": "0203",
      "market": "SHANGHAI",
      "authorID": [
        "11000235631"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "Access China conference highlights",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80044865",
      "orgName": "Deutsche Bank AG",
      "orgSName": "德意志银行",
      "publishDate": "2018-01-11 00:00:00.000",
      "infoCode": "AP201801111076703063",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000195635.Jack Hu",
        "11000259530.Megan Xu"
      ],
      "indvIsNew": "001",
      "researcher": "Jack Hu,Megan Xu",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "78.1000000000",
      "indvAimPriceL": "78.1000000000",
      "attachType": "0",
      "attachSize": 251,
      "attachPages": 8,
      "encodeUrl": "GenzcyFHPzdbQVFLx88OHuuL8d7/8Ms2z9JJQZtDruc=",
      "sRatingName": "Buy",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000195635",
        "11000259530"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "BTK抑制剂授权TGTherapeutics，“走出去”战略加速推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2018-01-11 00:00:00.000",
      "infoCode": "AP201801111076693800",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "53.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000242527.徐曼"
      ],
      "indvIsNew": "001",
      "researcher": "徐曼",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 491,
      "attachPages": 5,
      "encodeUrl": "GenzcyFHPzdbQVFLx88OHo+s2rApu4kZn+FxnqTU3zs=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000242527"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "授权BTK抑制剂，海外创新药战略显成效",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2018-01-10 00:00:00.000",
      "infoCode": "AP201801101076125456",
      "column": "002004006001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3500000000",
      "predictLastYearPe": "55.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000249332.肖汉山"
      ],
      "indvIsNew": "001",
      "researcher": "肖汉山",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 735,
      "attachPages": 9,
      "encodeUrl": "5p2VpBhEojvFS1dJiXssRmPeB7onOeKUzX3Xt5CFn+c=",
      "sRatingName": "谨慎推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000249332"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "JAK1抑制剂授权海外企业，公司创新及国际化持续推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2018-01-05 00:00:00.000",
      "infoCode": "AP201801051074376568",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3500000000",
      "predictLastYearPe": "52.2000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 499,
      "attachPages": 5,
      "encodeUrl": "WpCYnWT0ei2Gf0ajjV5I1vQ07qrSH9QNOK+lhijBdDg=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新国际化步伐加快，SHR0302成功海外授权",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2018-01-05 00:00:00.000",
      "infoCode": "AP201801051074234209",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "50.0600000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 813,
      "attachPages": 4,
      "encodeUrl": "WpCYnWT0ei2Gf0ajjV5I1tAi6pxiunEGaOLbVEiEu2I=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "吡咯替尼临床数据优异，有望加速获批上市",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2017-12-12 00:00:00.000",
      "infoCode": "AP201712121065478643",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "49.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 805,
      "attachPages": 4,
      "encodeUrl": "Q9rq9kFj49zoI7RTHWuA636mhG6NfLeEBynSpMPxaMI=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "Pyrotinib P2 data better than Kadcyla",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80044865",
      "orgName": "Deutsche Bank AG",
      "orgSName": "德意志银行",
      "publishDate": "2017-12-12 00:00:00.000",
      "infoCode": "AP201712121065294796",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3900000000",
      "predictLastYearPe": "46.9000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000195635.Jack Hu",
        "11000259530.Megan Xu"
      ],
      "indvIsNew": "001",
      "researcher": "Jack Hu,Megan Xu",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "78.1000000000",
      "indvAimPriceL": "78.1000000000",
      "attachType": "0",
      "attachSize": 635,
      "attachPages": 13,
      "encodeUrl": "Q9rq9kFj49zoI7RTHWuA65yJjVj+0bU4KeDg2VxX/jQ=",
      "sRatingName": "Buy",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000195635",
        "11000259530"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "推出限制性股票激励计划，业绩承诺高彰显公司发展雄心",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2017-11-06 00:00:00.000",
      "infoCode": "AP201711061015620661",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3500000000",
      "predictLastYearPe": "51.1000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 423,
      "attachPages": 5,
      "encodeUrl": "B7ywBZ/8OWjNQW07bdnGS3V6kNzmDE3EapFrlfmwhck=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "Patient enrollment completed for pivotal cHL study, earlier than expected",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80044865",
      "orgName": "Deutsche Bank AG",
      "orgSName": "德意志银行",
      "publishDate": "2017-11-06 00:00:00.000",
      "infoCode": "AP201711061015594716",
      "column": "002004006001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "46.8000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000195635.Jack Hu",
        "11000259530.Megan Xu"
      ],
      "indvIsNew": "001",
      "researcher": "Jack Hu,Megan Xu",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "69.0000000000",
      "indvAimPriceL": "69.0000000000",
      "attachType": "0",
      "attachSize": 379,
      "attachPages": 9,
      "encodeUrl": "B7ywBZ/8OWjNQW07bdnGS7lRO+uN2lutNwwOlyOeWpA=",
      "sRatingName": "Buy",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000195635",
        "11000259530"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "限制性股票激励计划出炉，高价位执行彰显信心",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2017-11-02 00:00:00.000",
      "infoCode": "AP201711021000334839",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "49.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 799,
      "attachPages": 4,
      "encodeUrl": "WAL/guearV5rwh+MPQJ/Clgbrl8cTzBH+HzHfywkoc8=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩增速持续加快，研发回报渐行渐近",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80101832",
      "orgName": "交银国际证券",
      "orgSName": "交银国际证券",
      "publishDate": "2017-10-24 00:00:00.000",
      "infoCode": "AP201710240973897732",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3600000000",
      "predictLastYearPe": "52.8000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000259170.赵心怡"
      ],
      "indvIsNew": "001",
      "researcher": "赵心怡",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "71.6700000000",
      "indvAimPriceL": "71.6700000000",
      "attachType": "0",
      "attachSize": 978,
      "attachPages": 5,
      "encodeUrl": "Yh4lyaGmRaCkdM5krNeqQNmnJXNXk6eOJi16KNBcMWI=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000259170"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩稳定增长，创新与仿制药布局稳步推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2017-10-20 00:00:00.000",
      "infoCode": "AP201710200966219592",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4000000000",
      "predictLastYearPe": "47.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000249332.肖汉山"
      ],
      "indvIsNew": "001",
      "researcher": "肖汉山",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 579,
      "attachPages": 4,
      "encodeUrl": "BOZp7qN1ysxMn0mgh5eDkSE+1NQwbt1mKKPN/KHEOOg=",
      "sRatingName": "谨慎推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000249332"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2017年三季报点评：业绩增速提升，龙头优势突显",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000155",
      "orgName": "上海证券有限责任公司",
      "orgSName": "上海证券",
      "publishDate": "2017-10-19 00:00:00.000",
      "infoCode": "AP201710190963182222",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3400000000",
      "predictLastYearPe": "47.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000235631.杜臻雁"
      ],
      "indvIsNew": "001",
      "researcher": "杜臻雁",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 464,
      "attachPages": 4,
      "encodeUrl": "s2pPFfBr5KYr8qMUeK83Nc5NDmiBATFnGm00HkwKEcA=",
      "sRatingName": "增持",
      "sRatingCode": "0203",
      "market": "SHANGHAI",
      "authorID": [
        "11000235631"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "三季报业绩符合预期，国内外研发创新攻城拔寨",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2017-10-19 00:00:00.000",
      "infoCode": "AP201710190963045478",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3600000000",
      "predictLastYearPe": "46.8100000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 631,
      "attachPages": 6,
      "encodeUrl": "s2pPFfBr5KYr8qMUeK83NRtik664IqXF0CVz8nCBr+o=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2017年三季报点评：收入业绩均呈逐季加速趋势，强者“恒”强龙头三季度创新持续推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2017-10-19 00:00:00.000",
      "infoCode": "AP201710190962531062",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3600000000",
      "predictLastYearPe": "47.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210529.张金洋",
        "11000249425.胡偌碧"
      ],
      "indvIsNew": "001",
      "researcher": "张金洋,胡偌碧",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "1",
      "attachSize": 128,
      "attachPages": 10,
      "encodeUrl": "s2pPFfBr5KYr8qMUeK83NQe/5z2TdvTrFknQOobRMng=",
      "sRatingName": "推荐",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000210529",
        "11000249425"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩符合预期，大品种研发获突破",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2017-10-19 00:00:00.000",
      "infoCode": "AP201710190962269273",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "45.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 802,
      "attachPages": 4,
      "encodeUrl": "s2pPFfBr5KYr8qMUeK83NcFVdeqbO9P3z2pLS1ojbdA=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "事件点评：重磅创新吡咯替尼II期数据申报生产，迅速进入优先审评超预期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2017-09-27 00:00:00.000",
      "infoCode": "AP201709270914276451",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3600000000",
      "predictLastYearPe": "43.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210529.张金洋",
        "11000249425.胡偌碧"
      ],
      "indvIsNew": "001",
      "researcher": "张金洋,胡偌碧",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 665,
      "attachPages": 9,
      "encodeUrl": "xG0jkp3cIg8JlN/W1tvbk6AzQFGC3i8VGQax3fO1K9E=",
      "sRatingName": "推荐",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000210529",
        "11000249425"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "主流品种增长强劲，研发支撑长期业绩",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80101832",
      "orgName": "交银国际证券有限公司",
      "orgSName": "交银国际证券",
      "publishDate": "2017-09-07 00:00:00.000",
      "infoCode": "AP201709070863899076",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3500000000",
      "predictLastYearPe": "47.1000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000259170.赵心怡"
      ],
      "indvIsNew": "001",
      "researcher": "赵心怡",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "63.5500000000",
      "indvAimPriceL": "63.5500000000",
      "attachType": "0",
      "attachSize": 897,
      "attachPages": 5,
      "encodeUrl": "fUP3X8dadwRRgbboo2B4qDU90kkXWMyrx8ODwiJy19Y=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000259170"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩符合预期，研发与国际化助推持续发展",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2017-09-06 00:00:00.000",
      "infoCode": "AP201709060862239615",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3800000000",
      "predictLastYearPe": "39.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000171584.李锋",
        "11000239345.蔡明子"
      ],
      "indvIsNew": "001",
      "researcher": "李锋,蔡明子",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 583,
      "attachPages": 4,
      "encodeUrl": "gK4g6norcYeMyzVuY+PKSmVQDATgRhKrer1Um7Y7YYc=",
      "sRatingName": "谨慎推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000171584",
        "11000239345"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司业绩符合预期，加大研发力度提升公司产品线竞争力",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2017-09-01 00:00:00.000",
      "infoCode": "AP201709010844849213",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3600000000",
      "predictLastYearPe": "39.7200000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 736,
      "attachPages": 6,
      "encodeUrl": "NenOFe95mtaV8j9AI7sp6nioY4B8TOkKZgIjKhXQrEU=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "Expecting growth acceleration in 2018",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80044865",
      "orgName": "德意志银行",
      "orgSName": "德意志银行",
      "publishDate": "2017-08-31 00:00:00.000",
      "infoCode": "AP201708310842522187",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "38.4000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000195635.Jack Hu"
      ],
      "indvIsNew": "001",
      "researcher": "Jack Hu",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "60.5000000000",
      "indvAimPriceL": "60.5000000000",
      "attachType": "0",
      "attachSize": 369,
      "attachPages": 11,
      "encodeUrl": "cLOf9A3dKSFNQgOn5Xm1TJoos9JA5UF1Tjj649L7cmI=",
      "sRatingName": "Buy",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000195635"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2017年中报点评：上半年业绩符合预期，制剂出口稳步推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000155",
      "orgName": "上海证券有限责任公司",
      "orgSName": "上海证券",
      "publishDate": "2017-08-31 00:00:00.000",
      "infoCode": "AP201708310842099823",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3000000000",
      "predictLastYearPe": "42.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000235631.杜臻雁"
      ],
      "indvIsNew": "001",
      "researcher": "杜臻雁",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 348,
      "attachPages": 4,
      "encodeUrl": "cLOf9A3dKSFNQgOn5Xm1TM6hcOiaUhVghh1Pr6ntBcs=",
      "sRatingName": "增持",
      "sRatingCode": "0203",
      "market": "SHANGHAI",
      "authorID": [
        "11000235631"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2017年中报点评：中报业绩稳健符合预期，加大研发力度创新药龙头蓄势待发",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2017-08-31 00:00:00.000",
      "infoCode": "AP201708310841382286",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3600000000",
      "predictLastYearPe": "40.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210529.张金洋"
      ],
      "indvIsNew": "001",
      "researcher": "张金洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 596,
      "attachPages": 11,
      "encodeUrl": "cLOf9A3dKSFNQgOn5Xm1TJCjuHJL4U5ViwzsAGIegmo=",
      "sRatingName": "推荐",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000210529"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩增长符合预期，静待大品种获批",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2017-08-30 00:00:00.000",
      "infoCode": "AP201708300838041736",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000236240.施跃"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,施跃",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "61.0000000000",
      "indvAimPriceL": "61.0000000000",
      "attachType": "0",
      "attachSize": 806,
      "attachPages": 4,
      "encodeUrl": "hiwWyzYVvCBf9HbRHK8g2J97MVULPx3sTIiNAFeoEQE=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000236240"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "超重磅吡咯替尼报产，上市预期大概率提前",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2017-08-28 00:00:00.000",
      "infoCode": "AP201708280833905496",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "39.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000236240.施跃"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,施跃",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "61.0000000000",
      "indvAimPriceL": "61.0000000000",
      "attachType": "0",
      "attachSize": 1255,
      "attachPages": 9,
      "encodeUrl": "X03iIbieDcO/i7JeENcoFplkDsanKJiPiwYyNhiqdb0=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000236240"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "Pyrotinib NDA filed; expect approval in 2H18",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80044865",
      "orgName": "Deutsche Bank AG",
      "orgSName": "德意志银行",
      "publishDate": "2017-08-25 00:00:00.000",
      "infoCode": "AP201708250826944210",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000195635.Jack Hu"
      ],
      "indvIsNew": "001",
      "researcher": "Jack Hu",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "58.5000000000",
      "indvAimPriceL": "58.5000000000",
      "attachType": "0",
      "attachSize": 171,
      "attachPages": 8,
      "encodeUrl": "nbziilJ691BMsraSHLvuv779gvXaDxbYCpwz4lo0yFk=",
      "sRatingName": "Buy",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000195635"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "Updates on middle/late-stage pipeline",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80044865",
      "orgName": "Deutsche Bank AG",
      "orgSName": "德意志银行",
      "publishDate": "2017-08-14 00:00:00.000",
      "infoCode": "AP201708140799113013",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.7200000000",
      "predictLastYearPe": "31.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000195635.Jack Hu"
      ],
      "indvIsNew": "001",
      "researcher": "Jack Hu",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "58.5000000000",
      "indvAimPriceL": "58.5000000000",
      "attachType": "0",
      "attachSize": 2540,
      "attachPages": 53,
      "encodeUrl": "oeMJHAXPj+OfhN9hyzRXNMoex+bv5RgijpK9kN6sGSg=",
      "sRatingName": "Buy",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000195635"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "阿帕替尼新进国家医保",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80102043",
      "orgName": "Phillip Securities (Hong Kong) Ltd",
      "orgSName": "辉立证券",
      "publishDate": "2017-08-02 00:00:00.000",
      "infoCode": "AP201708020763676070",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 1,
      "reportType": 2,
      "author": [
        "11000181877.范国和"
      ],
      "indvIsNew": "001",
      "researcher": "范国和",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "56.5000000000",
      "indvAimPriceL": "56.5000000000",
      "attachType": "0",
      "attachSize": 459,
      "attachPages": 5,
      "encodeUrl": "glFuCfVd8rEdAzl7MuW6wMq5IlNz9udfvk7huPmXg+g=",
      "sRatingName": "Accumulate(增持)",
      "sRatingCode": "0102",
      "market": "SHANGHAI",
      "authorID": [
        "11000181877"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "阿帕替尼新进国家医保，放量或将加速",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2017-07-25 00:00:00.000",
      "infoCode": "AP201707250742690987",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "35.4100000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000236240.施跃"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,施跃",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "56.0000000000",
      "indvAimPriceL": "56.0000000000",
      "attachType": "0",
      "attachSize": 1233,
      "attachPages": 9,
      "encodeUrl": "WJmmBjn691gdXOHPGuBiqYilq9vd+bS+mYcnx0vdZOg=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000236240"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "吸入用地氟烷海外获批 制剂出口稳步推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000155",
      "orgName": "上海证券有限责任公司",
      "orgSName": "上海证券",
      "publishDate": "2017-07-19 00:00:00.000",
      "infoCode": "AP201707190728230599",
      "column": "002004006001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3000000000",
      "predictLastYearPe": "38.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000235631.杜臻雁"
      ],
      "indvIsNew": "001",
      "researcher": "杜臻雁",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 461,
      "attachPages": 5,
      "encodeUrl": "WWcvVr+8E0Uy4kIG+AnYQNxj6Mtq0hrPANa79fwJDOs=",
      "sRatingName": "增持",
      "sRatingCode": "0203",
      "market": "SHANGHAI",
      "authorID": [
        "11000235631"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "地氟烷欧盟获批上市，制剂出口步伐加快",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2017-07-18 00:00:00.000",
      "infoCode": "AP201707180725942491",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "34.7900000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000236240.施跃"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,施跃",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "56.0000000000",
      "indvAimPriceL": "56.0000000000",
      "attachType": "0",
      "attachSize": 661,
      "attachPages": 4,
      "encodeUrl": "0I9UgGYUk5YngS/deRHcdfrgGMlFqMtjGfs8CNwEGIA=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000236240"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "事件点评：地氟烷欧盟获批，国内进入优先审评，恒瑞霸主地位不可动摇",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2017-07-17 00:00:00.000",
      "infoCode": "AP201707170724662607",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3600000000",
      "predictLastYearPe": "36.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210529.张金洋"
      ],
      "indvIsNew": "001",
      "researcher": "张金洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 979,
      "attachPages": 8,
      "encodeUrl": "9OJ2L8A4EGixPyjq4qyfOidTSAC68gL1OG7IJi0mPvU=",
      "sRatingName": "推荐",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000210529"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "紫杉醇重磅剂型进优先审评，有望获批首仿",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2017-06-27 00:00:00.000",
      "infoCode": "AP201706270671887306",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.4100000000",
      "predictLastYearPe": "36.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000236240.施跃"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,施跃",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "56.0000000000",
      "indvAimPriceL": "56.0000000000",
      "attachType": "0",
      "attachSize": 1208,
      "attachPages": 8,
      "encodeUrl": "Mn23cghJhZ7H4Zx7elDIiLPwb1rlf3k9OAFKtxna0Is=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000236240"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "白蛋白紫杉醇获优先审评；研发进展顺利",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80056613",
      "orgName": "北京高华证券有限责任公司",
      "orgSName": "高华证券",
      "publishDate": "2017-06-23 00:00:00.000",
      "infoCode": "AP201706230665401400",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.3500000000",
      "predictLastYearPe": "41.3000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "004",
      "emRatingValue": "0",
      "emRatingName": "中性",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000245836.陈子易"
      ],
      "indvIsNew": "001",
      "researcher": "陈子易",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "55.7900000000",
      "indvAimPriceL": "55.7900000000",
      "attachType": "0",
      "attachSize": 287,
      "attachPages": 5,
      "encodeUrl": "sy8frDXxPJh3aen5HUM1CilIKkmiQYxqLDoc/r0yXfI=",
      "sRatingName": "中性",
      "sRatingCode": "0102",
      "market": "SHANGHAI",
      "authorID": [
        "11000245836"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "19K获优先审评，过10亿重磅获批可期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2017-05-26 00:00:00.000",
      "infoCode": "AP201705260604000275",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.6900000000",
      "predictLastYearPe": "35.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000236240.施跃"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,施跃",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 811,
      "attachPages": 4,
      "encodeUrl": "tHTHgWRbkQfM7Xr2g/gQQgk5EsFDLuastVEYNJX0T94=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000236240"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "事件点评：19K进入优先审评，阿帕替尼后又一个10亿级别创新药",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2017-05-24 00:00:00.000",
      "infoCode": "AP201705240599666711",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.6400000000",
      "predictLastYearPe": "37.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210529.张金洋"
      ],
      "indvIsNew": "001",
      "researcher": "张金洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 992,
      "attachPages": 9,
      "encodeUrl": "m1jqCSMMP0/OkqikNXC3RAUQD5jWb8u/xvxeRjatfqU=",
      "sRatingName": "推荐",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000210529"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "稳健经营，多品种获批国内外临床和生产",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2017-04-21 00:00:00.000",
      "infoCode": "AP201704210521411578",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.6900000000",
      "predictLastYearPe": "33.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000236240.施跃"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,施跃",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 802,
      "attachPages": 4,
      "encodeUrl": "UI0N8VHansU35KrYwDIMbexOpAdULhJ68Zd76beVwbA=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000236240"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2017年一季报点评：一季报业绩稳健符合预期，海内外捷报频传",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2017-04-21 00:00:00.000",
      "infoCode": "AP201704210521068576",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.6400000000",
      "predictLastYearPe": "34.1100000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210529.张金洋"
      ],
      "indvIsNew": "001",
      "researcher": "张金洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 744,
      "attachPages": 7,
      "encodeUrl": "UI0N8VHansU35KrYwDIMbQoxdn9/ZoBkNSFYjtbHW5I=",
      "sRatingName": "推荐",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000210529"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药布局继续加强，ANDA批文稳步推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2017-04-21 00:00:00.000",
      "infoCode": "AP201704210519902433",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.6000000000",
      "predictLastYearPe": "31.8000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000172706.李敬雷"
      ],
      "indvIsNew": "001",
      "researcher": "李敬雷",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "60.0000000000",
      "indvAimPriceL": "60.0000000000",
      "attachType": "0",
      "attachSize": 636,
      "attachPages": 4,
      "encodeUrl": "UI0N8VHansU35KrYwDIMbdalUOxV7UQ5X2tKF1eZDDw=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000172706"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "国际化提升企业发展弹性 创新药推动公司业绩增长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2017-03-17 00:00:00.000",
      "infoCode": "AP201703170414451747",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.6300000000",
      "predictLastYearPe": "31.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 908,
      "attachPages": 7,
      "encodeUrl": "anKXrISlOR03J22mi+/5eIx4QXOFwR8dQju5XMZbuMs=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "点评报告：卡泊芬净海外获批，公司发展再添动力",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000199",
      "orgName": "爱建证券有限责任公司",
      "orgSName": "爱建证券",
      "publishDate": "2017-03-16 00:00:00.000",
      "infoCode": "AP201703160411528616",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.5800000000",
      "predictLastYearPe": "32.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000175095.侯佳林"
      ],
      "indvIsNew": "001",
      "researcher": "侯佳林",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 633,
      "attachPages": 5,
      "encodeUrl": "MtW5yxbg2DOwFSC+J5v3WT0fljnmty7enJDoSpIgavA=",
      "sRatingName": "推荐",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000175095"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩基本符合预期，创新和海外业绩支撑未来",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2017-03-15 00:00:00.000",
      "infoCode": "AP201703150408805210",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.6000000000",
      "predictLastYearPe": "31.8200000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000172706.李敬雷"
      ],
      "indvIsNew": "001",
      "researcher": "李敬雷",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "60.0000000000",
      "indvAimPriceL": "58.4000000000",
      "attachType": "0",
      "attachSize": 646,
      "attachPages": 4,
      "encodeUrl": "/qaad0LN8XG2CG95ePOsNsqW50Hi8nHrmvjF7ZAjVfo=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000172706"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "年报点评：稳健前行",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80092743",
      "orgName": "华融证券股份有限公司",
      "orgSName": "华融证券",
      "publishDate": "2017-03-14 00:00:00.000",
      "infoCode": "AP201703140406978927",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.6800000000",
      "predictLastYearPe": "30.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000206336.张科然"
      ],
      "indvIsNew": "001",
      "researcher": "张科然",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 400,
      "attachPages": 3,
      "encodeUrl": "7cT57ezwyosmrOvvWBZ/geyBkWoMOukR9X7ruoeKgFU=",
      "sRatingName": "推荐",
      "sRatingCode": "0102",
      "market": "SHANGHAI",
      "authorID": [
        "11000206336"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩不及预期：2017年前景完好，关键临床试验如期推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80056613",
      "orgName": "北京高华证券有限责任公司",
      "orgSName": "高华证券",
      "publishDate": "2017-03-14 00:00:00.000",
      "infoCode": "AP201703140406949636",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.6100000000",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000245836.陈子易"
      ],
      "indvIsNew": "001",
      "researcher": "陈子易",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "54.8300000000",
      "indvAimPriceL": "54.8300000000",
      "attachType": "0",
      "attachSize": 306,
      "attachPages": 5,
      "encodeUrl": "7cT57ezwyosmrOvvWBZ/gfwd8HJG7c+Au/5vv+cwIx8=",
      "sRatingName": "买入",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000245836"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩增长稳健，创新基因驱动长远发展",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000199",
      "orgName": "爱建证券有限责任公司",
      "orgSName": "爱建证券",
      "publishDate": "2017-03-14 00:00:00.000",
      "infoCode": "AP201703140406100244",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.5800000000",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000175095.侯佳林"
      ],
      "indvIsNew": "001",
      "researcher": "侯佳林",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 523,
      "attachPages": 4,
      "encodeUrl": "7cT57ezwyosmrOvvWBZ/ge4Q084DBHy5JS/VFMcUn1s=",
      "sRatingName": "推荐",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000175095"
      ],
      "count": 1,
      "orgType": "white"
    }
  ],
  "TotalPage": 7,
  "pageNo": 6,
  "currentYear": 2025
}